Results 201 to 210 of about 73,173 (211)

The European Medicines Agency review of vemurafenib (Zelboraf®) for the treatment of adult patients with BRAF V600 mutation-positive unresectable or metastatic melanoma: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use

European Journal of Cancer, 2013
Jan Schellens, Tomáš Salmonson, Serena Marchetti   +2 more
exaly  

The European Medicines Agency’s Approach to Transparency

2019
Stefano Marino, Spyridon Drosos
openaire   +1 more source

European Medicines Agency to move to Amsterdam

Nature, 2017
openaire   +1 more source

European medicines agency opens for business

Veterinary Record, 1995
openaire   +1 more source

European Medicines Agency

openaire   +1 more source

Should the European Medicines Agency consider ageing a disease?

Bioethics
Guillermo Marin Penella
exaly  

The European Medicines Agency

openaire   +1 more source

Relocation of the European Medicines Agency to Dublin

2017
openaire   +1 more source

The European Medicines Agency (EMA)

openaire   +1 more source

The European Medicines Agency Approach

2010
exaly